The Advertising Standards Agency (ASA) has pulled adverts from Clearasil, Johnson & Johnson, online retailer, and Dermalogica’s MediBack range in a bid to clampdown on misleading claims, according to a report by The Drum.

Focused on claims regarding acne products, the ASA banned the adverts for making medicinal claims about unlicensed products. Following advice from the Medicines and Healthcare products Regulatory Agency (MHRA), the ASA  stated that the acne treatment products should be held to the same regulations as other medical devices and treatments.

While the companies refute the claims that the products were intentionally advertised as medicinal treatments, the ASA stated that the products “must not appear again in the form complained about.”

It continued that the companies must “not make medicinal claims for unlicensed products, in particular claims that their products could prevent or treat acne.”